Table 3 Study characteristics
Study | Infusion of Mag | Treatment initiation of Mag | Route of Mag | Treatment Duration of Mag (hours) | Total dose of Mag (mmol) | Type of BBs | Definitions of AA with continuous ECG |
|---|---|---|---|---|---|---|---|
Bert et al. [19] | Magnesium sulfate | Postop | Iv | 96 | 49 | Propranolol | POAT including AF, AFL, or a SVT that was sustained >5 minutes and warranted pharmacologic therapy |
Cook et al. [22] | Magnesium sulfate | Preop | Iv | 120 | 102 | Atenolol | AA lasting >30 minutes or causing hemodynamic compromise requiring immediate intervention |
Forlani et al. [20] | Magnesium sulfate | Preop | Iv | 144 | 37 | Sotalol | AF that required treatment for symptoms or hemodynamic deterioration |
Geertman et al. [21] | Magnesium chloride | Preop | Iv | 36 | 75 | Sotalol | POAT including AF,AFL, and multifocal atrial tachycardia |
Solomon et al. [23] | Magnesium sulfate | Postop | Iv | 24 | 73 | Propranolol | AF lasting longer than 1 hour or requiring therapy as a result of hemodynamic compromise |